Study examines effectiveness of antiviral drug to treat mononucleosis
University of Minnesota researchers have begun studying a new drug to treat infectious mononucleosis, commonly known as mono. – University of Minnesota researchers have begun studying a new drug to treat infectious mononucleosis, commonly known as mono. The goal of the study is to find out if people who take the antiviral drug valomaciclovir recover from mono faster.